We are live on ! Find out more
NAM

Needelman Asset Management Portfolio holdings

AUM $46M
1-Year Est. Return 8.27%
This Fund
S&P 500
This Quarter Est. Return
+2.06%
1 Year Est. Return
+8.27%
3 Year Est. Return
+30.52%
5 Year Est. Return
+74.86%
10 Year Est. Return
–
AUM
$38.8M
AUM Growth
+$1.47M
Cap. Flow
+$677K
Cap. Flow %
1.74%
Top 10 Hldgs %
37.69%
Holding
38
New
1
Increased
11
Reduced
19
Closed
1
Avg Time Held
14 quarters
Top 10 Avg Time Held
7.6 quarters
Top 20 Avg Time Held
9.8 quarters

Top Buys

Rank Stock Value
1
VYX icon
NCR Voyix
VYX
+$1.4M
2
KHC icon
The Kraft Heinz Company
KHC
+$17.7K
3
GE icon
GE Aerospace
GE
+$10.7K
4
T icon
AT&T
T
+$10.3K
5
AAPL icon
Apple
AAPL
+$8.87K

Top Sells

Rank Stock Value
1
TEVA icon
Teva Pharmaceutical Industries Limited
TEVA
+$520K
2
ELV icon
Elevance Health
ELV
+$67.4K
3
UNH icon
UnitedHealth
UNH
+$61K
4
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$20.8K
5
MKL icon
Markel Group
MKL
+$19.4K

Sector Composition

Rank Sector Weight
1 Healthcare 24.15%
2 Financials 22.74%
3 Technology 15.59%
4 Consumer Staples 12.17%
5 Industrials 10.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
BAC icon
1
Bank of America
BAC
$375B
$1.73M 4.44%
71,136
-600
-0.8% -$14K
2013 Q2
16 quarters
UNH icon
2
UnitedHealth
UNH
$333B
$1.68M 4.32%
9,057
-348
-4% -$61K
2013 Q2
16 quarters
ELV icon
3
Elevance Health
ELV
$87B
$1.67M 4.3%
8,870
-375
-4% -$67.4K
2013 Q2
16 quarters
MSFT icon
4
Microsoft
MSFT
$3.88T
$1.49M 3.84%
21,665
-225
-1% -$15.4K
2015 Q3
7 quarters
JPM icon
5
JPMorgan Chase
JPM
$881B
$1.45M 3.73%
15,858
-100
-0.6% -$8.63K
2013 Q2
16 quarters
VYX icon
6
NCR Voyix
VYX
$953M
$1.38M 3.56%
+55,216
New +$1.4M
2017 Q2
0 quarters
HON icon
7
Honeywell
HON
$65.5B
$1.33M 3.42%
11,032
-61
-0.5% -$7.2K
2013 Q2
16 quarters
MKL icon
8
Markel Group
MKL
$21.9B
$1.31M 3.37%
1,340
-20
-1% -$19.4K
2013 Q4
14 quarters
BRK.B icon
9
Berkshire Hathaway Class B
BRK.B
$1.09T
$1.3M 3.35%
7,695
-125
-2% -$20.8K
2013 Q2
16 quarters
ABT icon
10
Abbott
ABT
$170B
$1.3M 3.35%
26,782
– –
2013 Q2
16 quarters
JNJ icon
11
Johnson & Johnson
JNJ
$618B
$1.3M 3.35%
9,835
-90
-0.9% -$11.5K
2013 Q2
16 quarters
CB icon
12
Chubb
CB
$133B
$1.18M 3.04%
8,111
-65
-0.8% -$9.15K
2016 Q1
5 quarters
DEO icon
13
Diageo
DEO
$48.4B
$1.11M 2.85%
9,242
-20
-0.2% -$2.38K
2013 Q2
16 quarters
INTC icon
14
Intel
INTC
$566B
$1.1M 2.84%
32,745
+150
+0.5% +$5.37K
2013 Q2
16 quarters
AON icon
15
Aon
AON
$58.8B
$1.1M 2.84%
8,300
-20
-0.2% -$2.53K
2013 Q2
16 quarters
EMR icon
16
Emerson Electric
EMR
$88.7B
$1.04M 2.67%
17,395
-60
-0.3% -$3.56K
2013 Q2
16 quarters
PFE icon
17
Pfizer
PFE
$159B
$1.02M 2.63%
32,068
-158
-0.5% -$4.98K
2013 Q2
16 quarters
CVX icon
18
Chevron
CVX
$415B
$1.01M 2.61%
9,700
– –
2013 Q2
16 quarters
GE icon
19
GE Aerospace
GE
$317B
$990K 2.55%
7,645
+78
+1% +$10.7K
2013 Q2
16 quarters
PG icon
20
Procter & Gamble
PG
$350B
$987K 2.54%
11,325
+15
+0.1% +$1.32K
2013 Q2
16 quarters
KMB icon
21
Kimberly-Clark
KMB
$32.5B
$978K 2.52%
7,573
-40
-0.5% -$5.2K
2013 Q2
16 quarters
QCOM icon
22
Qualcomm
QCOM
$188B
$928K 2.39%
16,805
+20
+0.1% +$1.12K
2013 Q2
16 quarters
KHC icon
23
The Kraft Heinz Company
KHC
$26.7B
$920K 2.37%
10,738
+195
+2% +$17.7K
2015 Q3
7 quarters
FLR icon
24
Fluor
FLR
$6.82B
$893K 2.3%
19,510
+100
+0.5% +$4.79K
2013 Q2
16 quarters
AAPL icon
25
Apple
AAPL
$4.97T
$876K 2.26%
24,324
+240
+1% +$8.87K
2013 Q2
16 quarters
1
2

Similar funds

PRHC
P.R. Herzig & Co Roslyn Heights, New York $45.9M AUM 15.88% 1-Year Est. Return
BC
Breogan Capital New York $56.4M AUM
SCPM
Social Capital PEP Management Palo Alto, California $56.5M AUM
SAM
Senzar Asset Management New York $34.7M AUM 0.56% 1-Year Est. Return
BCP
Blum Capital Partners San Francisco, California $34.1M AUM 1.14% 1-Year Est. Return
AVA
Accel VIII Associates Palo Alto, California $65.1M AUM
GG
Gores Group Beverly Hills, California $22.3M AUM 4.58% 1-Year Est. Return
SM
SLS Management New York $17.2M AUM 14.82% 1-Year Est. Return

Needelman Asset Management's Q2 2017 Portfolio in Review

As of Q2 2017, Needelman Asset Management held 38 positions worth $38.8M, up 3.9% from $37.4M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Needelman Asset Management's Q2 2017 filing shows 1 new, 11 increased, 19 reduced and 1 closed positions. Its largest new stake was NCR Voyix: 55,216 shares worth $1.38M. The largest sale was Teva Pharmaceutical Industries Limited, an estimated $520K.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 25% a quarter earlier, followed by Financials and Technology.

  • Needelman Asset Management's largest Q2 2017 buy was NCR Voyix: 55,216 shares worth $1.38M.
  • Needelman Asset Management added most to The Kraft Heinz Company in Q2 2017, an estimated $17.7K increase.
  • Needelman Asset Management's biggest Q2 2017 reduction was Elevance Health, cutting an estimated $67.4K.
  • Needelman Asset Management fully exited Teva Pharmaceutical Industries Limited in Q2 2017, selling an estimated $520K.
  • Needelman Asset Management's ten largest holdings make up 38% of its $38.8M portfolio in Q2 2017.
  • Needelman Asset Management opened 1 new position and closed 1 in Q2 2017.
  • Needelman Asset Management's portfolio value rose 3.9% quarter-over-quarter to $38.8M.

Based on Needelman Asset Management's 13F filing for Q2 2017, filed 7 Jul 2017.